Why are cures no longer profitable? In this investigative documentary, we expose the pharmaceutical industry’s transition from medical breakthroughs to a lifelong subscription model. From the 1910 Flexner Report to the 2018 Goldman Sachs report, we follow the money to reveal how chronic disease became a business strategy.
🚨 TL;DR: Modern medicine has been rewired to prioritize management over remission. This video explores the historical "education cull" of 1910, the patent thickets of the 1980s, and the vertical monopolies of CVS and Aetna that keep patients locked in a cycle of refills.
Stop being a customer and start being a patient again. We’re breaking down the engineering of demand through food, the regulatory capture of the FDA, and the "orphan playbook" used to skyrocket drug prices.
📌 In This Video: 0:00 - The 1910 Flexner Report: The Audit That Changed Everything 0:15 - Shocking Claim: Cures are a "Bad Business Model" 0:30 - The Stakes: Why Your Health is a Subscription 10:00 - Building the Monopoly: Foundations Patents 20:00 - The 1980 Bayh-Dole Act University Profits 30:00 - Chronic Disease as a Business Model 40:00 - Engineering Demand: The Sugar Food Industry Lie 50:00 - The CVS-Aetna Loop: Vertical Integration Exposed 1:00:00 - Erasing Alternatives: Why Non-Patent Medicine is Marginalized 1:10:00 - Whistleblowers Billion-Dollar Fines 1:20:00 - Precision Subscriptions: The Future of Data-Driven Care 1:30:00 - The Care That Threatens the Model: Reversal Remission 1:40:00 - Policy Solutions Personal Agency
